These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9589047)

  • 61. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q.
    Tsuda H; Hirohashi S
    Cancer Res; 1995 Aug; 55(15):3395-8. PubMed ID: 7614478
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression.
    Schwarzenbach H; Eichelser C; Kropidlowski J; Janni W; Rack B; Pantel K
    Clin Cancer Res; 2012 Oct; 18(20):5719-30. PubMed ID: 23014523
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lack of association between LOH in the 9p region and clinicopathologic parameters in primary breast cancer.
    Vieira de Oliveira SF; Oliveira MM; Urban CA; de Lima RS; Cavalli IJ; Ribeiro EM
    Cancer Genet Cytogenet; 2010 Jul; 200(1):23-7. PubMed ID: 20513530
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas.
    Kerangueven F; Noguchi T; Coulier F; Allione F; Wargniez V; Simony-Lafontaine J; Longy M; Jacquemier J; Sobol H; Eisinger F; Birnbaum D
    Cancer Res; 1997 Dec; 57(24):5469-74. PubMed ID: 9407952
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic impact of multiple allelic losses on metastatic recurrence in hepatocellular carcinoma after curative resection.
    Nishida N; Fukuda Y; Komeda T; Ito T; Nishimura T; Minata M; Kuno M; Katsuma H; Ikai I; Yamaoka Y; Nakao K
    Oncology; 2002; 62(2):141-8. PubMed ID: 11914600
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
    Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
    Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
    [TBL] [Abstract][Full Text] [Related]  

  • 68. LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia.
    Amari M; Suzuki A; Moriya T; Yoshinaga K; Amano G; Sasano H; Ohuchi N; Satomi S; Horii A
    Oncol Rep; 1999; 6(6):1277-80. PubMed ID: 10523696
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
    Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
    Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.
    Eiriksdottir G; Johannesdottir G; Ingvarsson S; Björnsdottir IB; Jonasson JG; Agnarsson BA; Hallgrimsson J; Gudmundsson J; Egilsson V; Sigurdsson H; Barkardottir RB
    Eur J Cancer; 1998 Dec; 34(13):2076-81. PubMed ID: 10070314
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
    Nagahata T; Hirano A; Utada Y; Tsuchiya S; Takahashi K; Tada T; Makita M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
    Breast Cancer; 2002; 9(3):208-15. PubMed ID: 12185331
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer.
    Försti A; Louhelainen J; Söderberg M; Wijkström H; Hemminki K
    Eur J Cancer; 2001 Jul; 37(11):1372-80. PubMed ID: 11435067
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Allelic instability as a predictor of survival in Egyptian breast cancer patients.
    Zekri AR; Bahnassi AA; Bove B; Huang Y; Russo IH; Rogatko A; Shaarawy S; Shawki OA; Hamza MR; Omer S; Khaled HM; Russo J
    Int J Oncol; 1999 Oct; 15(4):757-67. PubMed ID: 10493959
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Microsatellite changes in nipple aspirate fluid and breast tissue from women with breast carcinoma or its precursors.
    Zhu W; Qin W; Ehya H; Lininger J; Sauter E
    Clin Cancer Res; 2003 Aug; 9(8):3029-33. PubMed ID: 12912952
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q.
    Al-Mulla F; AlFadhli S; Al-Hakim AH; Going JJ; Bitar MS
    J Clin Pathol; 2006 Jun; 59(6):624-30. PubMed ID: 16731603
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset).
    Lo YL; Yu JC; Huang CS; Tseng SL; Chang TM; Chang KJ; Wu CW; Shen CY
    Int J Cancer; 1998 Dec; 79(6):580-7. PubMed ID: 9842965
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas.
    Larson PS; de las Morenas A; Bennett SR; Cupples LA; Rosenberg CL
    Am J Pathol; 2002 Jul; 161(1):283-90. PubMed ID: 12107113
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelial cancer and lack of relation to chemotherapy response and outcome.
    Sengeløv L; Christensen M; von der Maase HD; Horn T; Marcussen N; Kamby C; Orntoft T
    Cancer Genet Cytogenet; 2000 Dec; 123(2):109-13. PubMed ID: 11156735
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of allelic losses at 3p25.1, 13q12, or 17p13.3 with poor prognosis in breast cancers with lymph node metastasis.
    Haga S; Emi M; Hirano A; Utada Y; Kajiwara T; Akiyama F; Sakamoto G; Takahashi K; Tada T; Kasumi F; Miki Y; Nakamura Y
    Jpn J Cancer Res; 2001 Nov; 92(11):1199-206. PubMed ID: 11714444
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of high-risk breast cancer patients from genetic changes of their tumors.
    Watatani M; Inui H; Nagayama K; Imanishi Y; Nishimura K; Hashimoto Y; Yamauchi E; Hojo T; Kotsuma Y; Yamato M; Matsunami N; Yasutomi M
    Surg Today; 2000; 30(6):516-22. PubMed ID: 10883462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.